To Wnd whether the plasma Wbronectin (FN) molecular status can be useful to diVerentiate between rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The expression of plasma FN domains was determined by ELISA using monoclonal domain-speciWc antibodies. FN molecular forms were revealed by immunoblotting and analyzed by densitometry. The following Wndings were found: (1) FN at 200 mg/l (58% of sensitivity, 56% of speciWcity) and 350 mg/l (58% of sensitivity, 58% of speciWcity) in SLE, as well as at 295 mg/l (52% of sensitivity, 51% of speciWcity) and 460 mg/l in RA (70% of sensitivity, 73% of speciWcity). (3) The plasma FN immunopatterns, characterized by the presence of high-molecular (260-310 kDa) and/or low-molecular (158-209 kDa) FN bands, were speciWc only for SLE samples. The analysis of plasma FN status revealed by its Fibrin-Heparin-, CBD-and Ct-domain reactivity with monoclonal antibody and immunoblotting can be helpful to diVerentiate the SLE in respect to RA and normal plasmas.
Introduction
Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) belong to the group of inXammatory rheumatic diseases. Diagnosing of RA and SLE is a clinically driven process using diVerent biomarkers which could be informative to prescribe disease susceptibility, diagnosis and activity [1] . Among potential SLE biomarkers are: anti-dsDNA and anti-nucleosome autoantibodies, complement, acute phase proteins, cytokines and soluble cytokine receptors [2] . In RA, inXammatory markers, autoantibodies and bone markers potentially prognose radiological damage [3, 4] .
Fibronectin (FN) is a multidomain and multifunctional glycoprotein engaged in processes associated with cellmatrix interactions. It is reported to play an important role in extracellular matrix (ECM) remodeling, adhesion, migration, proliferation, transformation, tissue repair, wound healing and hemostasis [5] . FN found in the ECM originates from various cells (e.g., Wbroblasts, chondrocytes), is trapped into insoluble multimeric Wbrills, while that present in plasma derives from liver hepatocyte synthesizes, and is a soluble, compact globular dimer [6] . Plasma FN is believed to be biologically inactive. Although in the presence of endothelial injury and during the repair processes, the plasma FN can enter the extravascular space, changes the conformation from globular to Wbrillar, forms multimers and aggregates to form a provisional matrix [7] . FN is able to bind, via its multiple domains, a number of macromolecules, including Wbrin, Wbrinogen, heparin, collagen, C-reactive protein, rheumatoid factor and complement components [8] .
Our previous results indicate profound degradation of synovial FN in RA occurs only locally in joint tissues, the primary site of the pathology. In the RA blood plasma, FN did not undergo fragmentation, and some of its domain expressions, although higher than those of normal plasma FN, were not associated with RA progression [9] . In the present work, we were focused whether the plasma FN concentration and FN molecular status revealed by immunoblotting in other than RA arthritis disease, namely SLE, can be related to the disease and may help to state the diVerential diagnosis. FN concentration was determined by ELISA with a set of speciWc monoclonal antibodies able to react with epitopes of structurally and functionally independent FN domains: the cell-( 
Materials and methods

Patients and samples
Patients (n = 41) who were attending the Rheumatology Clinic of the Wroclaw Medical University were included in the study after their informed consent had been given. Twenty-two samples were derived from RA patients and nineteen samples derived from patients with SLE patients (Table 1) . The study was approved by the local ethics committee (approval no 453/2007). All patients were evaluated from the results of clinical examination, plain X-rays Wndings and routine laboratory blood plasma parameters. Patients who had traumatic, septic, or microcrystalline arthritis, previous joint surgery, or isotopic synovectomy within the 12 months before the study were excluded. Blood was drawn from patients into plastic syringes and placed directly into tubes containing 1 mM phenylmethylsulfonyl Xuoride (PMSF, Sigma Chemical Co, St Louis, MO, USA). The samples were centrifuged, and blood plasmas were stored in small aliquots at ¡78°C until used.
RA was diagnosed according to ACR (American College of Rheumatology) classiWcation criteria from 1987 [10] . All patients suVered more than 2 years, and with respect to the radiographic outcome by scoring the X-rays of the patients' hands, the RA blood plasma samples were classiWed as a late RA [11] . SLE was diagnosed based on modiWed 1997 classiWcation criteria for SLE [12] .
All Ct FN (FN 1-1; M013) using Wve independent sandwich-type solid-phase enzyme-linked immunoassays (ELISA) according to a procedure described earlier [9] . The respective monoclonal antibody (diluted 10,000-times) was used as coating agents in the wells of a microtiter plate (Nalge Nunc International, Naperville, USA) to bind FN from the sample in the next step. The amount of FN bound by the monoclonal antibody was quantiWed by rabbit polyclonal anti-FN antibodies (diluted 5,000-times) and subsequent reaction with the secondary antibodies, that is, peroxidase-conjugated goat anti-rabbit immunoglobulins (diluted 10,000-times). Immunoblotting for FN molecular form determination Plasma FN (300 ng), determined by CBD FN-ELISA as described previously, was subjected to SDS polyacrylamide gel electrophoresis (SDS-PAGE) in a 7.5% gel under reducing conditions. After electrophoresis, the separated proteins were blotted onto nitrocellulose (Serva Electrophoesis GmbH, Heidelberg, Germany) as described earlier [9] . The blots were developed with mouse monoclonal antibody anti-CBD FN (FN 30-8, code M010, TaKaRa, Japan), diluted 1:10,000 in 5% casein in TBS, and then with rabbit anti-mouse immunoglobulins conjugated to horseradish peroxidase (Sigma, 1:10,000 dilution in 5% casein in TBS). The color reaction was developed with diaminobenzidine. Then, the blots were dried and analyzed. The molecular weights of the FN bands were determined using BioRad molecular-weight protein standards and intact human FN (MW 230 kDa; Sigma, St. Louis, MO, USA).
The relative amounts of the particular FN isoforms were expressed as the percentage of the total number of pixels in a lane. For this purpose, the blots were scanned and analyzed by densitometric GelScan v. 6.0 (Serva Electrophoresis).
Statistics
Data are presented as means § standard deviations (SD). The data were not normally distributed as calculated according to the Shapiro-Wilk W test; therefore, the nonparametric Mann-Whitney U test was used to determine diVerences between groups. The P values lower than 0.05 were regarded as signiWcant. Correlations between analyzed parameters and ESR as well as CRP were determined by the Spearman test. The diagnostic precision of the analyzed parameters was assessed using the receiver operating characteristic (ROC) curves. The area under the curve (AUC) quantiWed the diagnostic precision.
Results
FN domain concentration
The plasma FN domain concentrations showed no diVerences in relation to the patient's gender. Additionally, the FN domain concentrations showed no correlations with ESR and CRP levels (the range of r coeYcients, 0.01-0.2). Using the ROC curves, the optimal cut oV points of CBD FN at 295 mg/l with 52% of sensitivity and 51% of speciWcity (AUC 0.58), Ct FN at 460 mg/l with 70% of sensitivity and 73% of speciWcity (AUC 0.81) and Fibrin-Heparin FN at 45 mg/l with 75% of sensitivity and speciWcity (AUC 0.85) were determined in predicting RA (Fig. 2a, c,  e) . On the other hand, the cut oV points of CBD FN at 200 mg/l with 58% of sensitivity and 56% of speciWcity (AUC 0.6), Ct FN at 350 mg/l with 58% of sensitivity and 58% of speciWcity (AUC 0.65) and Fibrin-Heparin FN at 31 mg/l with 54% of sensitivity and 55% of speciWcity (AUC 0.54) were found in predicting SLE (Fig. 2b, d, f) .
Plasma FN molecular forms
Representative immunoblot patterns of plasma FN are presented in the Fig. 3 , and the mean values of the relative amounts of particular FN bands are given in Table 3 . The immunoblotting with anti-CBD FN monoclonal antibody revealed three types (A, B, C) of FN immunopatterns. The FN immunopattern A (Fig. 3, lanes 1-2) consisting from 230 to 240 kDa FN bands corresponding to not so well-separated native polypeptides was observed in 37% of SLE group (7/19 samples) and in 100% of samples of RA and normal groups.
The FN immunopattern B and C was found only in 21 and 42% of SLE samples (4/19 and 8/19 samples, respectively). The pattern B (Fig. 3, lanes 3-4) showed apart the presence of native FN bands (230 and 240 kDa), the high-molecular (260-310 kDa) as well as low-molecular Table 3 .
Discussion
Our Wndings indicate that plasma FN concentration was signiWcantly lower in SLE than in RA patients and normal individuals (Table 2) . Moreover, the low value of FN concentration was more frequently associated with the unusual FN immunoblotting patterns characterized by the presence of FN fragments and/or the high-molecular weight band series which appeared in immunoblotting of the most SLE, but in none of the RA and normal plasmas (Table 3 , Fig. 3) .
However, previous reports indicated elevated plasma FN level in SLE patients is [13] signiWcantly higher in patients Table 3 Quantitative analysis of plasma FN molecular forms in SLE and RA patient groups FN immunoblotting (Fig. 3) Table 3 ) represent immunoblotting of plasma samples: 1-normal, 2-RA, with active SLE than with nonactive disease [14] . It should be underlined that our results of FN determination by the set of domain-speciWc monoclonal antibodies do not correspond to total FN level measured by polyclonal antibodies used in previous studies. It may be because the FN domain epitopes can be masked by interfering with antibodies, other molecules, the FN ligands, such as respective cellular integrins, collagen and its fragments, Wbrin or glucosaminoglycans [15] . Additionally, the degradation of FN molecule by endogenous metalloproteinases, active during inXammatory diseases, can lead to damage of domain epitopes and/ or to exposition of cryptic functional sites. Moreover, a conformational alteration in one domain could have an eVect on conformation and stabilization of the nearest neighbor sites [16] .
Among analyzed FN domains, the most helpful seems to be the determination of FN concentration lower than 350 mg/l in SLE and higher than 460 mg/l in RA can predict the diseases with quite good sensitivity (58 and 70%, respectively) as well as speciWcity (58 and 73%, respectively). As the previous report indicates, the low Ct FN concentration and the concomitant presence of FN fragments have been observed by us in synovial Xuid of RA patients [9] . The FN fragments were also reported in the plasma of patients with active SLE [17] . Here, we have also shown that about 60% of analyzed SLE samples showed besides the 230 and 240-kDa FN bands corresponding to native FN, the presence of normally absent four FN fragments (having molecular weight from 158 to 209 kDa) and three to Wve high-molecular weight FN forms (from 260 to 310 kDa). They formed, respectively, about 16 and 24% of all FN forms reactive with anti-FN monoclonal antibody (immunopatterns B and C in Fig. 3 and Table 3 ). In contrast, in RA, the plasma FN was untouched (Fig. 3-lane 2 ), and its signiWcantly higher level resulted probably from the increased total FN production by hepatic cells in a response to systemic inXammation. It could not be excluded that the plasma FN molecules in autoimmune patients can represent apart the FN derived from hepatic cells, the signiWcant part of the FN of nonhepatic origins, that is, epithelial and/or endothelial cell productions. They could be synthesized by highly active immunological cells and/or epithelial and/or endothelial cells as native, intact molecules, and/or additionally they can appear as fragments derived from degraded extracellular matrix of blood vessel cells in SLE. The tissue erosive process happens exclusively in joints and around the joints of RA patients, where many extracellular components, among them synovial, but not plasma FN, undergo degradation [18, 19] . The Wndings are important because SLE and RA diVerentiation may be sometimes diYcult, particularly at the beginning of SLE when patients have joint pain without any systemic indicators [20] .
The FN fragments are thought to have many diverse activities [21] [22] [23] and among them an ability to form crosslinking complexes with FN, various extracellular matrix components and some blood plasma components such as Wbrin and Wbrinogen [24, 25] . A formation of multimeric cross-linking polymers lies on the base of repair processes at which FN takes a main role [26] . In 60% SLE patient plasma samples, we observed the presence of FN forms having molecular weight from 260 to 310 kDa (Fig. 3, Table 3 ). The high-molecular FN forms may partly result from the expression of alternatively spliced (ED-A, ED-B and IIICS) segments, either are highly glycosylated glycoforms, or may be formed by an FN linkage with some blood plasma, extracellular matrix components, or their fragments [27, 28] , or even smaller molecules such as homocysteine [29] .
In conclusion, the data presented here pointed out that the analysis of FN level based on its domain epitope expression and of FN molecular status revealed by immunoblotting can be helpful to diVerentiate SLE in respect to RA and healthy individuals. The observed FN molecular pattern can be related to the general molecular processes by which the plasma FN is used for tissue needs.
